VUMC’s REDCap serves pandemic response around the world

REDCap, the research data management tool created and powered by Vanderbilt University Medical Center, is serving extra duty as research teams and public health authorities around the world grapple with the COVID-19 pandemic.

McCoin, Jones lauded as ‘Women to Watch’ in health care

Nicole McCoin, MD, vice chair for Education and Keith D. Wrenn Residency Program director in Vanderbilt University Medical Center’s Department of Emergency Medicine, and Pam Jones, DNP, senior associate dean for Clinical and Community Partnerships for Vanderbilt University School of Nursing (VUSN), have been chosen as 2020 “Women to Watch” by Nashville Medical News.

New physician spotlight: Edward Yaghmour

Vanderbilt, AstraZeneca collaborate on new COVID-19 antibody research

After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.

Opioid prescriptions after childbirth linked to increased risk of overdose, persistent use

Women who are prescribed opioids after childbirth have an increased risk of persistent opioid use or other serious opioid-related events, including overdose, in their first year postpartum, according to a new study by Vanderbilt University Medical Center researchers. This is true regardless of whether the woman had a vaginal delivery or a cesarean section.

Staph’s activation of blood clotting

Staph bacteria may change the factor they use to activate blood clotting — to evade the immune response — a new study suggests.